Nanostructures of MIL-100 were synthesized and used as a drug delivery platform for two members of the Tetracycline family. Doxycycline monohydrate (DOX) and Tetracycline hydrochloride (TC) were loaded separately on nano-MIL-100 (nanoparticles of drug@carrier were abbreviated as DOX@MIL-100 and TC@MIL-100). Characterizations were carried out using FT-IR, XRD, BET, DLS, and SEM. The FT-IR spectra revealed that the drugs were loaded into the framework of the carrier. The XRD patterns of DOX@MIL-100 and TC@MIL-100 indicated that no free DOX or TC were present. It could be concluded that the drugs are well dispersed into the pores of nano-MIL-100. The microporosity of the carrier was confirmed by BJH data. BET analysis showed a reduction in the free surface for both DOX@MIL-100 and TC@MIL-100. The release of TC and DOX was investigated, and it was revealed that MIL-100 mediated the drug solubility in water, which in turn resulted in a decrease in the release rate of TC (accelerating in DOX case) without lowering the total amount of released drug. After 48 h, 96 percent of the TC was sustain released, which is an unprecedented amount in comparison with other methods.

Combined therapies emerge as an interesting tool to overcome limitations of traditional pharmacological treatments (efficiency, side effects). Among other materials, metal-organic frameworks (MOFs) offer versatilities for the accommodation of multiple and complementary active pharmaceutical ingredients (APIs): accessible large porosity, availability of functionalization sites, and biocompatibility. Here, we propose topical patches based on water-stable and biosafe Fe carboxylate MOFs (MIL-100 and MIL-127), the biopolymer polyvinyl alcohol (PVA) and two co-encapsulated drugs used in skin disorders (azelaic acid (AzA) as antibiotic, and nicotinamide (Nic) as anti-inflammatory), in order to develop an advanced cutaneous combined therapy. Exceptional MOF drug contents were reached (total amount 77.4 and 48.1 wt.% for MIL-100 and MIL-127, respectively), while an almost complete release of both drugs was achieved after 24 h, adapted to cutaneous delivery. The prepared cutaneous PVA-MOF formulations are safe and maintain the high drug-loading capacity (total drug content of 38.8 and 24.2 wt.% for MIL-100 and MIL-127, respectively), while allowing a controlled delivery of their cargoes, permeating through the skin to the active target sites. The total amount of drug retained or diffused through the skin is within the range (Nic), or even better (AzA) than commercial formulations. The presented results make these drug combined formulations promising candidates for new cutaneous devices for skin treatment.

Due to their efficiency and accessibility, benzodiazepines are widely manufactured and consumed and as a result, they can be found in almost all wastewaters. Among the materials that were used for the removal of drug contaminants from wastewater, metal–organic frameworks (MOFs) demonstrated unique properties. In this regard, a composite of carboxymethylated cellulose (CMC) and MIL-100(Fe) was prepared via a sonochemical method and used for the removal of lorazepam from wastewater in various conditions. A maximum capacity of 811 mg g⁻¹ was achieved which is considered a great improvement compared to bare MIL-100(Fe) (150 mg g⁻¹) and other previously reported adsorbents. It is noteworthy that the efficiency of the adsorbent did not reduce in the second and third cycle of adsorption/desorption. Moreover, the effect of pH, dose of adsorbent, isotherms and the kinetics of this process were studied using UV-vis and HPLC analyses and the adsorbents were fully characterized with PXRD, TGA, BET, SEM, ZP and FT-IR techniques. Our findings demonstrate that this composite is clearly a green, recyclable and efficient adsorbent for the removal of lorazepam and opens our way to further potential applications in the removal of other active pharmaceutical ingredients.

Sulfonic acid-functionalized MIL-101 exhibits 163% higher barium adsorption (141.9 vs. 54 mg g⁻¹) than pristine MIL-101, demonstrating enhanced water remediation via strong sulfonate-barium coordination.